Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Trends in Pharmacological Sciences|June 13, 2006
Slow antagonist dissociation and long-lasting in vivo receptor protectionGeorges Vauquelin, Isabelle Van LiefdeExpert Opinion on Drug Discovery|June 2, 2012
Radioligand dissociation measurements: potential interference of rebinding and allosteric mechanisms and physiological relevance of the biological model systemsGeorges Vauquelin, Isabelle Van LiefdeFundamental & Clinical Pharmacology|October 15, 2013
Avidity and positive allosteric modulation/cooperativity act hand in hand to increase the residence time of bivalent receptor ligandsGeorges Vauquelin, Giampiero Bricca, Isabelle Van LiefdeJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 8, 2006
Long-lasting angiotensin type 1 receptor binding and protection by candesartan: comparison with other biphenyl-tetrazole sartansGeorges Vauquelin, Frederik Fierens, Isabelle Van LiefdeTrends in Pharmacological Sciences|November 5, 2002
Models and methods for studying insurmountable antagonismGeorges Vauquelin, Isabelle Van Liefde, Patrick VanderheydenBritish Journal of Pharmacology|January 26, 2016
On the different experimental manifestations of two-state 'induced-fit' binding of drugs to their cellular targetsGeorges Vauquelin, Isabelle Van Liefde, David C SwinneyDrug Discovery Today. Technologies|January 3, 2016
Radioligand binding to intact cells as a tool for extended drug screening in a representative physiological contextGeorges Vauquelin, Isabelle Van Liefde, David C SwinneyCurrent Topics in Medicinal Chemistry|July 2, 2015
The Role of Binding Kinetics in GPCR Drug DiscoveryDavid C Swinney, Brad A Haubrich, Isabelle Van Liefde, et al.Biochemical Pharmacology|April 26, 2008
Antagonist-radioligand binding to D2L-receptors in intact cellsAnn Packeu, Jean-Paul De Backer, Isabelle Van Liefde, et al.Pageof 1